HPS Pharmacies wishes to advise that Victorian access to COVID therapies on the National Medication Stockpile (NMS) is coming to an end in April 2024.
COVID therapies held by the NMS have the following expiry dates:
- Paxlovid® (nirmatrelvir + ritonavir) – expiry end of January 2024
- Lagevrio® (molnupiravir) – expiry end of January 2024
- Veklury® (remdesivir) – expiry end of April 2024
If a prescriber wishes to prescribe one of these therapies after this time, it must be supplied through the Pharmaceutical Benefits Scheme (PBS) or written as a private prescription. PBS criteria for Paxlovid® and Lagevrio® are available on the PBS website; Veklury® does not currently have a PBS indication.
Retain this notice in a prominent position, including in other related business units for at least one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates